Shanghai Pharmaceuticals Holding Co.,Ltd.’s Net Profit Rose 11.6% in First Three Quarters of 2022

Shanghai Pharmaceuticals Holding Co.,Ltd. (上海医药集团股份有限公司) (601607.SH) reported a net profit of 6 billion yuan in the first three quarters of 2022, up 11.6% year-on-year.

Meanwhile, the company posted 174.6 billion yuan in revenue, up 8.5% year-on-year.

At the end of the reporting period, it had 194.6 billion yuan in total assets and 118 billion yuan in total liabilities, with a liability-to-asset ratio of 60.6%.